Is SCPH or RYLD a better dividend investment in 2026?

SCPH currently yields 35.27% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: SCPH offers higher current income.

What is the dividend yield difference between SCPH and RYLD?

SCPH has a forward dividend yield of 35.27% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 22.88 percentage points.

Home › Compare › SCPH vs RYLD

SCPH vs RYLD: Dividend Comparison 2026

SCPH yields 35.27% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SCPH wins by $133.3K in total portfolio value

INVESTMENT

TIME HORIZON10 years

SCPH

● Live price

35.27%

Share price

$5.67

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$178.6K

Annual income

$27,157.20

Full SCPH calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — SCPH vs RYLD

📍 SCPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SCPH	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SCPH + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SCPH pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCPH

Annual income on $10K today (after 15% tax)

$2,998.24/yr

After 10yr DRIP, annual income (after tax)

$23,083.62/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, SCPH beats the other by $20,803.09/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCPH + RYLD for your $10,000?

SCPH: 50%RYLD: 50%

100% RYLD50/50100% SCPH

Portfolio after 10yr

$111.9K

Annual income

$14,920.09/yr

Blended yield

13.33%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SCPH right now

SCPH

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$8.12

+43.2% upside vs current

Range: $5.35 — $13.00

Altman Z

-7.3

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCPH buys

RYLD buys

No recent congressional trades found for SCPH or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSCPHRYLD

Forward yield	35.27% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$178.6K ✓	$45.3K
Annual income after 10y	$27,157.20 ✓	$2,682.98
Total dividends collected	$129.2K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: SCPH vs RYLD ($10,000, DRIP)

Year	SCPH Portfolio	SCPH Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$14,227	$3,527.34	$11,939	$1,239.34	+$2.3K → SCPH
2	$19,913	$4,690.15	$14,158	$1,382.89	+$5.8K → SCPH
3	$27,442	$6,135.14	$16,682	$1,532.59	+$10.8K → SCPH
4	$37,265	$7,901.67	$19,537	$1,687.64	+$17.7K → SCPH
5	$49,902	$10,028.00	$22,752	$1,847.20	+$27.1K → SCPH
6	$65,945	$12,549.99	$26,355	$2,010.43	+$39.6K → SCPH
7	$86,061	$15,499.75	$30,376	$2,176.45	+$55.7K → SCPH
8	$110,989	$18,904.51	$34,847	$2,344.43	+$76.1K → SCPH
9	$141,544	$22,785.49	$39,800	$2,513.54	+$101.7K → SCPH
10	$178,609	$27,157.20	$45,269	$2,682.98	+$133.3K → SCPH

SCPH vs RYLD: Complete Analysis 2026

SCPH — Stock

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Full SCPH Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this SCPH vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCPH vs SCHD SCPH vs JEPI SCPH vs O SCPH vs KO SCPH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.